Cardinal Systems is proud to take part in ODYSSEA

Sunday, 4^th October in the morning

at ‘Bois de Vincennes’ for 5 kms and 10 km

For the 2^nd year, Cardinal Systems has chosen to take part into Odyssea run against breast cancer.

Funds will be redistributed to ‘Institut Gustave Roussy’ for research on personalized treatment of breast cancer.

Breast cancer is the most frequent cancer and the main reason of mortality in woman between the ages of 35 and 55 years. In France, it is responsible for more than 11 000 deaths per year - 19 % of females killed by cancer and 40 % of premature deaths (before 65 years old). In recent years, the mortality rate linked to breast cancer has fallen notably through early diagnosis and the development of better treatments. The earlier the diagnosis is, the greater the chance of a successful treatment.

For more about ODYSSEA: http://www.odyssea.info/pages/contact.php

Cardinal Systems offers clinical trials services with high added-value since 1996 to pharmaceutical industries, biotechnologies and governmental and non profit organizations in the development of new therapeutics.

Aligned with the Critical Path 2004, Cardinal Systems proposes innovative design and robust technology in order to go forward with new drug development for unmet medical needs.

Cardinal Systems has been participating in healthcare improvement through international clinical trials for over a decade, and enhances its partnerships with biotechnologies.